Dasatinib Metabolite D |
|
| Synonyms: 4’-Hydroxy Dasatinib;N-(2-Chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; | |
| Cat. No.: D25013 | CAS No.: 910297-57-3 |
| MDL.: | Formula: C22H26ClN7O3S |
| F.W.504 | Purity: 99％ |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | D25013 | CAS No.: | 910297-57-3 | |
| MDL: | Formula: | C22H26ClN7O3S | ||
| F.W.: | 504 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Jaworski, T., et al.: Xenobiotica, 21, 1451 (1991),Shah, N., et al.: Science, 305, 399 (2004), O'Hare, T., et al.: Cancer Res., 65, 4500 (2005), Das, J., et al.: J. Med. Chem., 49, 6819 (2006), Christopher, L., et al.: Drug Metab. Dispos., 36, 1341 (2008 | |||
| Application: | An oxidative metabolite of Dasatinib (M20 metabolite); used in the treatment of cancers and immune diseases. | |||
| Category: | Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds | |||